Skip to main content
. 2020 Aug 19;9(8):444–455. doi: 10.1002/psp4.12536

Table 1.

PK/PD model parameters

Model Parameter Symbol Unit Value RSE (%) IIV (%) RSE IIV (%)
PK AZD9567 Lag time
tlag
h 0.183 2 12a 14a
Absorption rate constant
ka0
h−1 38.2 32 72a 8a
Relative bioavailability
F
1b 20 9
Central volume of distribution
Vc
L 26.8 4
Intercompartment clearance
Q
L h−1 0.500 8
Peripheral volume of distribution
Vp
L 392 13 108 17
Clearance
CL
L h−1 3.70 6 27 9
Covariate model (dose on F)
s
mg−1 0.00253 12
Covariate model (dose on ka)
λ
0.103 32
Covariate model (dose on ka)
α
mg−1 0.0592 19
Residual error
σ
% 10.9 5
PK prednisolone No. of transit compartments
n
8.11 12 61 15
Mean transit time
tm
h 0.772 7 41 10
Relative bioavailability
F
1b 17 15
Central volume of distribution
Vc
L 352 5
Inter‐compartment clearance
Q
L h−1 5.81 50
Peripheral volume of distribution
Vp
L 23.6 32
Clearance
CL
L h−1 110 3 12 12
Residual error
σ
% 35.5 7
PK/PD TNFα Baseline TNFα
E0
ng/L 28.6 × 103 4 36 8
Transduction rate constant
kt
h−1 0.308 12
Weighting parameter
w
0.216 12
Maximal inhibition, AZD9567
Imax
1b
Concentration for half‐maximal effect, total AZD9567
IC50
nM 765 10 46 16
Concentration for half‐maximal effect, unbound AZD9567
IC50
nM 4.87c
Sigmoidicity parameter, AZD9567
γ
1.40 7
Maximal inhibition, prednisolone
Imax
1b
Concentration for half‐maximal effect, unbound prednisolone
IC50
nM 17.0 10 16 33
Sigmoidicity parameter, prednisolone
γ
1.33 7
Residual error
σ
% 44.5 5

Reporting of percent IIV, IOV, and residual error was done using the approximation 100·2.

IIV, interindividual variability; IOV, interoccasion variability; PD, pharmacodynamic; PK, pharmacokinetic; RSE, relative standard error.

a

The IIV and RSE IIV columns are used for IOV for t lag and k a0.

b

Fixed, not estimated.

c

Derived from the estimate of IC50 for total AZD9567 concentrations using an unbound fraction of 0.637%.